All Clinical Trials
Mater conducts clinical trials in a range of therapeutic areas including Cancer, Nerouology, Medicine, Orthopaedics Surgery and Acute Care, and Mothers' and Babies Health. Clinical trials are an essential component of helathcare. They provide the evidence to evaluate the safety and efficacy of new treantments and diagnositics, and provide alternative treatment options for patients with unmet needs.
Participate in a study aimed at understanding how to improve health and wellbeing of older adults by preventing or slowing frailty.
The FITTEST Study: Supporting older people to take part in frailty prevention program
FOCUSau: Improving the wellbeing of people with advanced cancer and their family carers
Improving the wellbeing of people with advanced cancer and their family carers: An effectiveness implementation trial of an Australian dyadic digital health intervention (FOCUSau).
FUZION: Efficacy and safety of guselkumab in participants with fistulizing, perianal Crohn’s Disease
FUZION: Efficacy and safety of guselkumab in participants with fistulizing, perianal Crohn’s Disease
Do you have newly diagnosed with advanced follicular lymphoma?
A Study to Assess the Efficacy and Safety of Golcadomide and Rituximab in Participants with Newly Diagnosed Advanced Stage Follicular Lymphoma
How does your blood/genetics influence how well pain relief works in cancer?
HyNOVA - Hyperthermic and Normothermic intraperitoneal chemotherapy following interval cytoreductive surgery for stage III epithelial OVArian, fallopian tube and primary peritoneal cancer
This study is investigating the safety of administering heated (42 degrees Celsius) versus normal temperature (37 degrees Celsius) chemotherapy during surgery for ovarian cancer patients.
Ridstress2 - Improving outcomes for women and small babies.
Improve outcomes for women and small babies by improving blood flow to the baby in labour, to alleviate fetal distress.
Investigating the effect of targeted chest physiotherapy on acute lung collapse in mechanically ventilated neonates using lung ultrasound..
Do you have an advanced solid tumour?
This study will investigate the use of a new medicine called INX-315 which may be used in the future as a possible treatment for advanced solid tumours.
Do you have a confirmed advanced solid tumor?
A Phase 1a/1b, first-in-human, open-label, non-randomized, multicenter, dose-escalation and cohort expansion study to evaluate the safety, tolerability, efficacy, immunogenicity, pharmacokinetics, and pharmacodynamics of IOS-1002 administered alone and in combination with a PD-1 monoclonal antibody in advanced solid tumors.